Literature DB >> 1457469

Gas chromatographic/mass spectrometric analysis of stable isotopes of 3-methylhistidine in biological fluids: application to plasma kinetics in vivo.

J A Rathmacher1, G A Link, P J Flakoll, S L Nissen.   

Abstract

A simple and rapid method for measuring 3-methylhistidine (3MH) in plasma and urine is described. Internal standard, 1-methylhistidine (1MH), was added to plasma, acidified and absorbed onto cation-exchange columns. It was then eluted from columns, dried, and derivatized for gas chromatography/mass spectrometry. A major fragment of 3MH was monitored at 238 u and 3-methyl-(methyl-2H3)histidine (d3-3MH) (used for in vivo kinetics) at 241 u, whereas 1MH was monitored at 340 u and eluted 0.5 min later than 3MH. Standard curves for plasma analysis were linear and nanamole amounts of 3MH in plasma were determined with a precision of 3.5%. 3MH was also quantitated in urine; however, because of substantial amounts of 1MH, (18O2)1MH was used as the internal standard. Nanamole amounts of 3MH were determined in urine with a precision of 2.7%. Application of the 3MH analytical method was used to develop a kinetic compartmental model by using the stable isotope of 3MH, d3-3MH. Cattle, like humans, quantitatively excrete 3MH in the urine. A young bovine was injected with d3-3MH and the enrichment curve in plasma was evaluated in order to obtain a steady-state production rate of 3MH. The decay curve was modeled through the use of NIH-SAAM modeling program. The kinetics of d3-3MH from plasma were adequately described by a three-pool compartmental model. The de novo production rate of 3MH estimated in the calf was 665 mumol per day. This corresponded to an estimated fractional turnover rate of 1.56% per day, which was similar to estimates obtained from urine collections.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457469     DOI: 10.1002/bms.1200211107

Source DB:  PubMed          Journal:  Biol Mass Spectrom        ISSN: 1052-9306


  8 in total

1.  Suppression of mTORC1 activation in acid-α-glucosidase-deficient cells and mice is ameliorated by leucine supplementation.

Authors:  Adi Shemesh; Yichen Wang; Yingjuan Yang; Gong-She Yang; Danielle E Johnson; Jonathan M Backer; Jeffrey E Pessin; Haihong Zong
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-17       Impact factor: 3.619

2.  PKB signaling and atrogene expression in skeletal muscle of aged mice.

Authors:  Megan Gaugler; Alicia Brown; Erin Merrell; Maria DiSanto-Rose; John A Rathmacher; Thomas H Reynolds
Journal:  J Appl Physiol (1985)       Date:  2011-05-05

3.  Body composition and energy metabolism following Roux-en-Y gastric bypass surgery.

Authors:  Robyn A Tamboli; H Ayesha Hossain; Pamela A Marks; Aaron W Eckhauser; John A Rathmacher; Sharon E Phillips; Maciej S Buchowski; Kong Y Chen; Naji N Abumrad
Journal:  Obesity (Silver Spring)       Date:  2010-04-22       Impact factor: 5.002

4.  Oversupplying metabolizable protein in late gestation for beef cattle: effects on postpartum ruminal fermentation, blood metabolites, skeletal muscle catabolism, colostrum composition, milk yield and composition, and calf growth performance.

Authors:  Koryn S Hare; Katie M Wood; Carolyn Fitzsimmons; Gregory B Penner
Journal:  J Anim Sci       Date:  2019-01-01       Impact factor: 3.159

5.  Oversupplying metabolizable protein in late gestation for beef cattle: effects on prepartum BW, ruminal fermentation, nitrogen balance, and skeletal muscle catabolism.

Authors:  Koryn S Hare; Katie M Wood; Kortney Acton; Carolyn Fitzsimmons; Gregory B Penner
Journal:  J Anim Sci       Date:  2019-01-01       Impact factor: 3.159

6.  Post-ruminal branched-chain amino acid supplementation and intravenous lipopolysaccharide infusion alter blood metabolites, rumen fermentation, and nitrogen balance of beef steers.

Authors:  Clint A Löest; Garrett G Gilliam; Justin W Waggoner; Jason L Turner
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

7.  Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle loss.

Authors:  M Sheffield-Moore; E L Dillon; K M Randolph; S L Casperson; G R White; K Jennings; J Rathmacher; S Schuette; M Janghorbani; R J Urban; V Hoang; M Willis; W J Durham
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-09-06       Impact factor: 12.910

8.  The effects of 12 weeks of beta-hydroxy-beta-methylbutyrate free acid supplementation on muscle mass, strength, and power in resistance-trained individuals: a randomized, double-blind, placebo-controlled study.

Authors:  Jacob M Wilson; Ryan P Lowery; Jordan M Joy; J C Andersen; Stephanie M C Wilson; Jeffrey R Stout; Nevine Duncan; John C Fuller; Shawn M Baier; Marshall A Naimo; John Rathmacher
Journal:  Eur J Appl Physiol       Date:  2014-03-06       Impact factor: 3.078

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.